At a glance
ClinicalIndex Comparison RecordN/ACompleted· 23 enrolled
Drug / intervention
Glaucoma Drainage Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms
In Brief
A clinical study evaluating Glaucoma Drainage Device for Glaucoma. Completed, enrolled 23 participants across 1 site.
Detailed Summary
Assess the safety and performance of the Miami InnFocus Drainage Implant in patients suffering from glaucoma that is inadequately controlled on tolerated medical therapy with intraocular pressure greater than or equal to 18 mm Hg and less than or equal to 40 mm Hg.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesDominican Republic
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2007
First PostedOct 2008
Primary CompletionNov 2016
Study CompletionJan 2017
TodayJul 2026
First PostedOct 15, 2008
Enrollment StartOct 1, 2007
Primary CompletionNov 1, 2016
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 9.1 yearsPosted 17.7 years ago
Interventions
Glaucoma Drainage Devicedevice
Insertion of MIDI Arrow subconjunctivally with a fornix-based incision after pretreatment of scleral surface with 0.4 mg/mL MMC and insertion of MIDI Arrow tube through sclera into anterior chamber of eye